BIOMAT Database Logo BIOMAT Database Logo

Bioartificial pancreas research in Japan. 2004

Hiroo Iwata, and Hideki Simada, and Eisai Fukuma, and Takahisa Ibii, and Hideki Sato
Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan. iwata@frontier.kyoto-u.ac.jp

The bioartificial pancreas (BAP), a medical device enclosing insulin-secreting cells in a semipermeable membrane, is expected to physiologically control glucose levels, and thus to be able to inhibit development of serious chronic complications in diabetic patients. In this brief review, we introduce research activities on the development of the BAP in Japan, including membrane preparation for the BAP, evaluation of in vitro and in vivo BAP functions, and challenges for production of insulin-secreting cells from stem cells.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D004622 Embryo, Mammalian The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS. Embryonic Structures, Mammalian,Mammalian Embryo,Mammalian Embryo Structures,Mammalian Embryonic Structures,Embryo Structure, Mammalian,Embryo Structures, Mammalian,Embryonic Structure, Mammalian,Embryos, Mammalian,Mammalian Embryo Structure,Mammalian Embryonic Structure,Mammalian Embryos,Structure, Mammalian Embryo,Structure, Mammalian Embryonic,Structures, Mammalian Embryo,Structures, Mammalian Embryonic
D004867 Equipment Design Methods and patterns of fabricating machines and related hardware. Design, Equipment,Device Design,Medical Device Design,Design, Medical Device,Designs, Medical Device,Device Design, Medical,Device Designs, Medical,Medical Device Designs,Design, Device,Designs, Device,Designs, Equipment,Device Designs,Equipment Designs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013234 Stem Cells Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells. Colony-Forming Units,Mother Cells,Progenitor Cells,Colony-Forming Unit,Cell, Mother,Cell, Progenitor,Cell, Stem,Cells, Mother,Cells, Progenitor,Cells, Stem,Colony Forming Unit,Colony Forming Units,Mother Cell,Progenitor Cell,Stem Cell

Related Publications

Hiroo Iwata, and Hideki Simada, and Eisai Fukuma, and Takahisa Ibii, and Hideki Sato
Bioartificial pancreas.
April 1990, Transplantation proceedings,
Hiroo Iwata, and Hideki Simada, and Eisai Fukuma, and Takahisa Ibii, and Hideki Sato
Bioartificial pancreas.
April 1994, Transplantation proceedings,
Hiroo Iwata, and Hideki Simada, and Eisai Fukuma, and Takahisa Ibii, and Hideki Sato
Bioartificial pancreas.
March 1993, Diabetic medicine : a journal of the British Diabetic Association,
Hiroo Iwata, and Hideki Simada, and Eisai Fukuma, and Takahisa Ibii, and Hideki Sato
[Bioartificial pancreas].
September 2002, Nihon rinsho. Japanese journal of clinical medicine,
Hiroo Iwata, and Hideki Simada, and Eisai Fukuma, and Takahisa Ibii, and Hideki Sato
Bioartificial pancreas in pigs.
January 1990, Hormone and metabolic research. Supplement series,
Hiroo Iwata, and Hideki Simada, and Eisai Fukuma, and Takahisa Ibii, and Hideki Sato
Bioartificial pancreas use in diabetic pregnancy.
January 1999, ASAIO journal (American Society for Artificial Internal Organs : 1992),
Hiroo Iwata, and Hideki Simada, and Eisai Fukuma, and Takahisa Ibii, and Hideki Sato
Japan Pancreas Society research directory, 1998.
April 1998, Pancreas,
Hiroo Iwata, and Hideki Simada, and Eisai Fukuma, and Takahisa Ibii, and Hideki Sato
Agarose for a bioartificial pancreas.
July 1992, Journal of biomedical materials research,
Hiroo Iwata, and Hideki Simada, and Eisai Fukuma, and Takahisa Ibii, and Hideki Sato
Bioartificial pancreas: status and bottlenecks.
June 1990, The International journal of artificial organs,
Hiroo Iwata, and Hideki Simada, and Eisai Fukuma, and Takahisa Ibii, and Hideki Sato
Design of a bioartificial pancreas(+).
October 2010, Journal of investigative medicine : the official publication of the American Federation for Clinical Research,
Copied contents to your clipboard!